Becton Dickinson (BDX) Tops Q4 EPS by 27c, Revenues Beat; Offers FY21 EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. NOW
2. GOOGL
3. MSFT
4. FTNT
5. EBAY
6. CMG
7. TENB
8. BIIB
9. KLAC
10. CART

Go back to Becton Dickinson (BDX) Tops Q4 EPS by 27c, Revenues Beat; Offers FY21 EPS Outlook

BD Announces Fiscal Fourth Quarter And Full Year 2020 Results; Provides Fiscal 2021 Guidance

November 5, 2020 6:00 AM EST

FRANKLIN LAKES, N.J., Nov. 5, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.784 billion for the fourth fiscal quarter ended September 30, 2020.  This represents an increase of 4.4% over the prior-year period on both a reported and currency-neutral basis. 

"I'm extremely proud of the team for their execution this quarter, as we delivered sequential improvement across each of our segments and successfully launched our Veritor SARS-CoV-2 assay. Collectively, we drove mid-single-digit revenue growth, building on the strength of our COVID-19... More